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 A shuttle vector pHSG396Sp was constructed to perform gene expression using 20 
Sphingomonas subterranea as a host. A new lasso peptide biosynthetic gene cluster, 21 
derived from Brevundimonas diminuta, was amplified by PCR and integrated to afford a 22 
expression vector pHSG396Sp-12697L. The new lasso peptide brevunsin was 23 
successfully produced by S. subterranea, harboring the expression vector, with a high 24 
production yield (10.2 mg from 1 L culture). The chemical structure of brevunsin was 25 
established by NMR and MS/MS experiments. Based on the information obtained from 26 
the NOE experiment, the three-dimensional structure of brevunsin was determined, 27 
which indicated that brevunsin possessed a typical lasso structure. This expression 28 
vector system provides a new heterologous production method for unexplored lasso 29 
peptides that are encoded by bacterial genomes. 30 
 31 




A lasso peptide is a unique peptide, normally 15-25 amino acids in length, which 34 
possesses the common motif of a knot structure in the molecule. Based on its biosynthetic 35 
system, it is classified with the ribosomally biosynthesized and post-translationally 36 
modified peptides (RiPPs) [3, 26, 28, 36]. In the biosynthesis of the lasso peptide, an 37 
isopeptide bond is formed between the amino group of the N-terminal amino acid and the 38 
β- or γ-carboxyl group of Asp or Glu at the 7th - 9th position from the N-terminus, which 39 
results in a macrolactam ring [27, 31, 33]. The tail of the C-terminal linear peptide 40 
normally passes through the ring, which is defined as the “lasso” structure. The first lasso 41 
peptide, named microcin J25, was isolated from a culture of Escherichia coli [35]. The 42 
biosynthetic gene cluster for microcin J25 (about 4.8 kbp) was reported to include four 43 
genes: a precursor peptide coding gene (gene A: McjA), two maturation enzyme coding 44 
genes (gene B: McjB and gene C: McjC), and an ATP-binding cassette transporter gene 45 
(gene D: McjD) [37]. Normally, the lasso peptide biosynthetic genes in proteobacteria 46 
have the same set of the genes, although the transporter gene is optional. 47 
Recently the genome mining method has become a powerful tool to find new lasso 48 
peptides, due to the accumulation of bacterial genome data [29, 20, 13, 32]. The 49 
prediction system for RiPPs, named RODEO (Rapid ORF Description and Evaluation 50 
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Online), was developed, resulting in the discovery of six new lasso peptides [38]. The 51 
genome-mining approach and heterologous production using Escherichia coli as host 52 
cells have been performed to produce new lasso peptides [15, 14, 13, 12, 11, 10, 41]. To 53 
produce useful functional molecule by modifying natural lasso peptide, several attempts 54 
were reported. Recently, RGD peptide motif was integrated into the lasso peptide 55 
microcin J25 to yield recombinant microcin J25 which had a highly potent and selective 56 
αvβ3 integrin inhibitory activity [10]. The lasso peptide benenodin-1 was reported to 57 
exhibit conformational switching between two distinct threaded conformers upon 58 
actuation by heat, like a rotaxane switch [39]. In any case, the heterologous E. coli 59 
expression system is problematic in that the amount of the lasso peptide produced is not 60 
very high without engineering the DNA sequence of the gene cluster [40]. To exploit 61 
lasso peptide gene clusters, improved method to perform heterologous production 62 
system is needed to obtain larger amount of new lasso peptide. We recently found 63 
production of a new lasso peptide, named subterisin, in a culture of Sphingomonas 64 
subterranea with high yield (15.0 mg from 1 L culture) [24]. On the other hand, 65 
Hayashi and Kurusu reported the construction of stable shuttle vectors between E. coli 66 
and Sphingomonas species [8, 9].  The GC content of genome of S. subterranea is high 67 
(approximately 63 %) compared to that of Escherichia coli (approximately 50 %), so 68 
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there is an advantage to use S. subterranea as a host for expression of gene with high 69 
GC content. We proposed that expression of the lasso peptide biosynthetic genes with 70 
high GC content in S. subterranea could result in a large amount of production of the 71 
exogenous lasso peptide.  Based on this speculation, we accomplished the construction 72 
of a shuttle vector between E. coli - Sphingomonas sp. and heterologous production of a 73 
new lasso peptide named brevunsin in S. subterranea. Here, we describe the 74 
heterologous production and structure determination of the new lasso peptide brevunsin. 75 
Materials and methods 76 
Bacterial strains. 77 
The microorganisms (Bacterial strains including Sphingomonas subterrenea NBRC 78 
16086T, Sphingobium yanoikuyae NBRC 15102T, Brevundimonas diminuta NBRC 79 
12697T, Escherichia coli NBRC 102203T, Pseudomonas aeruginosa NBRC 12689T, 80 
Bacillus subtilis NBRC 13719T, Staphylococcus aureus NBRC 100910T, Micrococcus 81 
luteus NBRC 3333T; Yeast strains including Saccharomyces cerevisiae NBRC 2376, 82 
Schizosaccharomyces pombe NBRC 0340; fungi strains including Aspergillus niger 83 
NBRC 33023T, Aspergillus oryzae NBRC 4290 were obtained from the NBRC culture 84 
collection (NITE Biological Resource Center, Japan).   85 
Construction of the shuttle vector pHSG396Sp 86 
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For the template for PCR amplification, the plasmid pYAN1 was purified from the cells 87 
of Sphingobium yanoikuyae using an isolation kit (FastGene Plasmid Mini Kit, 88 
NIPPON Genetics Co. Ltd, Tokyo, Japan). To construct the shuttle vector pHSG396Sp, 89 
the sequence (1228 bp, including repA: WP_004213409.1) was amplified by PCR with 90 
the template (pYAN1) and the primer pair YAN1-F1 and YAN1-R2 (Table S1), using a 91 
high-fidelity Phusion polymerase (NEB, Frankfurt/Main, Germany), following the 92 
manufacturer’s instructions. The DNA fragment insert, including repA, and the 93 
pHSG396 vector (Takara Bio Inc., Shiga, Japan) were double digested with HindIII 94 
(NEB) and SalI (NEB), according to the manufacturer’s instructions. The DNA 95 
products were ligated using T4 DNA ligation mix (Takara Bio Inc.) to afford the shuttle 96 
vector pHSG396Sp. E. coli DH5α cells were transformed with 5 μL of the ligation 97 
mixture by chemical competence transformation, and the cells were plated on LB agar 98 
medium (5 g tryptone, 2.5 g yeast extract, 5 g NaCl, and 15 g agar in 1 L distilled water) 99 
containing chloramphenicol (final concentration: 20 μg/mL). The plasmid pHSG396Sp 100 
was purified using an isolation kit (FastGene Plasmid Mini Kit). 101 
Construction of the expression vector pHSG396Sp-12697L 102 
For the template for PCR amplification, genomic DNA was extracted from the cells of 103 
Brevundimonas diminuta using DNeasy Blood & Tissue (Qiagen, Venlo, Netherlands). 104 
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The DNA fragment, including the lasso peptide brevunsin biosynthetic gene cluster 105 
(2754 bp, breA, breB, and breC), was amplified by PCR with the template and the 106 
primer pair of 12697L-F and 12697L-R (Table S1), using a high-fidelity Phusion 107 
polymerase (NEB), following the manufacturer’s instructions. The DNA fragment 108 
insert, including the brevunsin biosynthetic gene cluster, and the shuttle vector 109 
pHSG396Sp were digested with XbaI (NEB) and KpnI (NEB), according to the 110 
manufacturer’s instructions. The DNA products were ligated using T4 DNA ligation 111 
mix (Takara Bio Inc.) to afford the vector pHSG396Sp-12697L. E. coli DH5α cells 112 
were transformed with 5 μL of the ligation mixture by chemical competence 113 
transformation, and the cells were plated on LB agar plates containing chloramphenicol 114 
(final concentration: 20 μg/mL). The plasmid pHSG396Sp-12697L was purified using 115 
an isolation kit (FastGene Plasmid Mini Kit). The DNA sequences of the plasmids 116 
(pHSG396Sp and pHSG396Sp-12697L) were determined by direct DNA sequencing 117 
using Applied Biosystems 3730xl (Thermo Fisher Scientific, Inc., Massachusetts, 118 
USA), as shown in Fig. S1 and S2. 119 
Transformation of the expression vector to Sphingobium subterranea 120 
The plasmid pHSG396Sp or pHSG396Sp-12697L was transformed into Sphingomonas 121 
subterranea using electroporation. The bacterium S. subterranea was cultured in 10 mL 122 
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of NBRC medium (number 802 liquid medium;10 g peptone, 2 g yeast extract, and 1 g 123 
MgSO4·7H2O in 1 L distilled water, pH 7.0) at 30 °C for 24 h with shaking at 50 rpm. 124 
The cells were cooled on ice for 30 min, followed by centrifugation (4000 rpm, 4 °C, 10 125 
min). The harvested cells were suspended in 10 ml of a cold 10% glycerol solution. 126 
After centrifugation (4000 rpm, 4 °C, 10 min), the cells were harvested and resuspended 127 
in 10 ml of a cold 10% glycerol solution. After centrifugation (4000 rpm, 4 °C, 10 min), 128 
the harvested cells were resuspended in 0.1 mL of a cold 10% glycerol solution for 129 
electroporation. The electroporation experiment for a 0.1 mL suspension of cells was 130 
performed with the program “Ec3” (Voltage: 3.0 kV, 1 pulse) using a MicroPulser (Bio-131 
Rad Laboratories, California, USA). After electroporation, 0.5 mL of Super Optimal 132 
Broth with Catabolic repressor (SOC) medium was immediately added to the cell 133 
suspension. For the recovery of damage, the cells were incubated at 30 °C for 2 h. Then, 134 
the S. subterranea cells were spread onto NBRC medium (number 802 agar medium; 10 135 
g peptone, 2 g yeast extract, 1 g MgSO4·7H2O, and 15 g agar in 1 L distilled water, pH 136 
7.0) containing chloramphenicol (final concentration: 10 μg/mL). After incubation at 137 
30 °C for 6 days, colonies were picked and checked by the colony PCR method to 138 
obtain S. subterranea harboring pHSG396Sp or pHSG396Sp-12697L. 139 
Isolation of brevunsin 140 
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Sphingomonas subterranea harboring pHSG396Sp-12697L was cultured using 1 L of 141 
modified basal medium [16] containing chloramphenicol (20 µg/mL, final concentration) 142 
with shaking of 120 rpm at 30 °C for 9 days. The modified basal medium was prepared 143 
by adding the inorganic compounds (K2SO4, 2 g; K2HPO4, 3 g; NaCl, 1 g; NH4Cl, 5 g; 144 
MgSO4•7H2O, 80 mg; CuCl2, 5 mg; MnSO4•H2O, 2.5 mg; FeCl3•6H2O, 5 mg; 145 
CaCl2•2H2O, 5 mg) in 1L of distilled water with adjusting pH 7.0.  After autoclaving, 146 
the medium was supplemented with separately sterilized glucose and yeast extract at final 147 
concentrations of 0.25%, 0.005%, respectively.  The culture including bacterial cells 148 
was evaporated using rotary evaporator to aqueous residue (about 20 mL). The aqueous 149 
residue was extracted with MeOH (300 mL). After filtration with paper filter (Wattman 150 
No. 1 filter, GE Healthcare Life Sciences, Illinois, USA), the MeOH extract was 151 
concentrated to aqueous residue using rotary evaporator. The aqueous residue was 152 
subjected to open column chromatography using hydrophobic resin CHP-20P (Mitsubishi 153 
Chemical Co., Tokyo, Japan), eluted with 10% MeOH, 60% MeOH, and 100% MeOH. 154 
The 60% MeOH fraction was subjected to HPLC analysis using ODS column (4.6 × 250 155 
mm, 5 µm, Wakopak Handy-ODS, Wako Pure Chemical Industries Ltd., Osaka, Japan) 156 
with gradient elution from 20% to 50% MeCN containing 0.05% trifluoroacetic acid for 157 
20 min with UV detector set at 220 nm to detect brevunsin (retention time, 12.1 min, Fig. 158 
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S3) along with subterisin (retention time, 13.4 min, Fig. S3).  For isolation of brevunsin, 159 
the 60% MeOH fraction was repeatedly subjected to HPLC purification using ODS 160 
column (4.6 × 250 mm, 5 µm, Wakopak Handy-ODS, Wako Pure Chemical Industries, 161 
Ltd., Osaka, Japan) with isocratic elution at 22% MeCN containing 0.05% trifluoroacetic 162 
acid with UV detector set at 220 nm to isolate 10.2 mg of brevunsin (retention time, 26.8 163 
min, Fig. S4).  The yield of brevunsin was weighed by precision balance (AW320, 164 
SHIMADZU Co., Tokyo, Japan). 165 
Treatment of cyanogen bromide 166 
Brevunsin (0.5 mg) was dissolved in 1 ml of 70% HCOOH and treated for 4h at room 167 
temparature with 0.1M cyanogen bromide. After cleavage, the reaction mixture was 168 
centrifuged at 14500 rpm and the supernatant was concentrated by rotary evaporator and 169 
completely lyophilized by freeze dryer. The residue was re-dissolved in 0.5 mL of 170 
methanol and subjected to reversed-phase HPLC purification using ODS column (4.6 × 171 
250 mm, 5 µm, Wakopak Handy-ODS, Wako Pure Chemical Industries Ltd.) with 172 
gradient elution from 20% to 70% MeCN containing 0.05% trifluoroacetic acid for 20 173 
min with UV detector set at 220 nm to yield cleaved brevunsin. 174 
Mass spectrometry experiments 175 
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Brevunsin or cleaved brevunsin was dissolved in 30% MeCN. The accurate mass 176 
measurement was conducted using a Fourier-transform ion cyclotron resonance (FT-177 
ICR) mass spectrometer (ApexII 70e, Bruker Daltonics).  Brevunsin sample was 178 
appropriately diluted with 50% MeOH containing 0.1% formic acid was, and supplied 179 
to FT-ICR mass spectrometer by direct infusion with electrospray ionization (ESI) in the 180 
positive polarity.  MALDI-TOF MS and MS/MS analysis was conducted using a 181 
MALDI-TOF/TOF mass spectrometer (4800 Plus TOF/TOF analyzer, Sciex, CA, 182 
USA).  Brevunsin sample was mixed with equal volume of α-Cyano-4-183 
hydroxycinnamic acid (4-CHCA) (Shimadzu GLC Ltd., Tokyo) matrix solution 184 
(prepared as 10 mg/mL in 50%AcCN containing 0.1% tri-fluoro acetic acid) in 1:1 ratio, 185 
and aliquot of the mixture (0.5 μL) was spotted onto a standard stainless plate. After 186 
dried up, MS and MS/MS spectra were measured in the positive-ion mode with an 187 
acceleration voltage of 20 kV. The mass spectrometer was tuned and calibrated using 188 
calibration standards of YOKUDELNA (JEOL, Tokyo, Japan) and the peptide mixture 189 
(Peptide Calibration Standard II, Bruker Daltonics), respectively, prior to the 190 
measurements. 191 
NMR experiments 192 
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A NMR sample was prepared by dissolving the purified peptide in 500 μl of dimethyl 193 
sulfoxide-d6 (DMSO-d6). All NMR spectra were obtained on Bruker Avance 600 and 194 
Avance III HD 800 spectrometers with quadrature detection in the phase-sensitive mode 195 
by States-TPPI (time proportional phase incrementation) and in the echo-antiecho 196 
mode. One-dimensional (1D) 1H, 13C, DEPT-135 spectra were recorded at 25 °C with 197 
15 ppm for proton and 239 ppm or 222 ppm for carbon. The following spectra were 198 
recorded at 20, 25, or 30 °C, respectively, with 15 ppm spectral widths in t1 and t2 199 
dimensions: two-dimensional (2D) double quantum filtered correlated spectroscopy 200 
(DQF-COSY), recorded with 512 and 1024 complex points in t1 and t2 dimensions; 2D 201 
homonuclear total correlated spectroscopy (TOCSY) with DIPSI2 mixing sequence, 202 
recorded with mixing time of 80 ms, 512 and 1024 complex points in t1 and t2 203 
dimensions; 2D nuclear Overhauser effect spectroscopy (NOESY), recorded with 204 
mixing times of 200 and 400 ms, 512 and 1024 complex points in t1 and t2 dimensions. 205 
2D 1H-13C heteronuclear single quantum correlation (HSQC) and heteronuclear multiple 206 
bond connectivity (HMBC) spectra were acquired at 25 °C in the echo-antiecho mode. 207 
The 1H-13C HSQC and HMBC spectra were recorded with 1024 × 512 complex points 208 
for 15 ppm in the 1H dimension and 160 ppm or 222 ppm in the 13C dimension, 209 
respectively, at a natural isotope abundance. 2D 1H-15N HSQC spectrum was recorded 210 
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with 1024 × 128 complex points for 15 ppm in the 1H dimension and 40 ppm in the 15N 211 
dimension at a natural isotope abundance. All NMR spectra were processed using 212 
TOPSPIN 3.5 (Bruker). Peak-picking and assignment were performed with Sparky 213 
program (UCSF, http://www.cgl.ucsf.edu/Research/Sparky.html). Before Fourier 214 
transformation, the shifted sinebell window function was applied to t1 and t2 215 
dimensions. All 1H and 13C dimensions were referenced to DMSO-d6 at 25 °C. 216 
Structure calculations 217 
Distance restraints were constructed from intensities of NOE cross peaks in 2D NOESY 218 
spectra with mixing times of 200 ms, which were classified into four distance categories 219 
(2.9, 3.5, 5.0, and 6.0 Å). Pseudo-atom corrections were made for non-stereospecifically 220 
assigned methylene and methyl resonance [39]. An additional 0.5 Å were added to the 221 
upper bounds for methyl protons [4]. Backbone Φ dihedral angle restraints were 222 
evaluated from 3JHNα values obtained from the high digital resolution 2D DQF-COSY 223 
spectrum and intraresidue and sequential NOEs. Backbone ϕ-angles were restrained to –224 
120° ± 40° for 3JHN-Hα = 8.5 – 9 Hz and –120° ± 30° for 3JHN-Hα > 9 Hz. The additional 225 
Φ dihedral angle restraint of 100° ± 80° was applied to residues for which the 226 
intraresidue HN-Hα NOE was clearly weaker than the NOE between HN and the Hα of 227 
the preceding residue [5]. The solution structure of brevunsin was calculated by 228 
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simulated annealing protocol using distant and dihedral angle restraints with the 229 
program CNS version 1.1 [2]. The Asp1-Glu9 isopeptide linkage was generated using a 230 
manual patch of the “protein-allhdg.top” CNS file modified from the manual patch of 231 
the “protein1.0.top” XPLOR-NIH file [34]. Three hundred structures were calculated, of 232 
which the 15 structures of lowest energy were selected for structural analysis. The final 233 
15 lowest-energy ensemble structures were analyzed by MOLMOL [23] and 234 
PROCHECK-NMR [25], and graphics were created by MOLMOL. The atomic 235 
coordinate data was deposited in the Protein Data Bank (PDB ID: 5ZCN). 236 
Thermostability test of brevunsin  237 
Concentration of brevunsin was adjusted to 0.5 mg/mL in DMSO.  Aliquot sample (100 238 
µl each) was heated at 50 °C, 65°C, 80 °C, and 95 °C for 1 hr, followed by immediate 239 
cooling to 4 °C. Each sample (50 µl) was subjected to HPLC analysis using ODS column 240 
(4.6 × 250 mm, 5 µm, Wakopak Handy-ODS, Wako Pure Chemical Industries Ltd., Osaka, 241 
Japan) with gradient elution from 20% to 60% MeCN containing 0.05% trifluoroacetic 242 
acid for 20 min with UV detector set at 220 nm. 243 
Modified Marfey’s method 244 
Brevunsin (1.0 mg) was subjected to acid hydrolysis with 6N HCl containing 3% phenol 245 
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and 1% mercaptoethanol at 110 ̊ C for 16 h for detection of amino acids. The hydrolysates 246 
were completely evaporated using rotary evaporator, followed by adding 200 μL of water. 247 
10 μL of Nα-(5-fluoro-2,4-dinitrophenyl)-L-leucinamide (L-FDLA, Tokyo Chemical 248 
Industry Co., Ltd, Tokyo, Japan) in acetone (10 μg/μL) and 100 μL of 1M NaHCO3 249 
solution were added to the hydrolysate and the mixture was incubated at 80 ˚C for 3 min. 250 
The reaction mixture was cooled down to room temperature before being neutralized with 251 
50 μL of 2N HCl and diluted with 1 mL of 50% MeCN. For standard amino acid, each 252 
amino acid was derivatized with L-FDLA and D-FDLA in the same method. 253 
Approximately 30 μL of each FDLA derivatives was subjected to HPLC analysis with 254 
C18 column (4.6 × 250 mm, Wakopak Handy ODS, WAKO Pure Chemical Industries 255 
Ltd.). The DAD detector (MD-2018, JASCO, Tokyo, Japan) was used for detection of the 256 
amino acid derivatives accumulating the data of the absorbance from 220nm to 420 nm. 257 
The HPLC analysis was performed at a flow rate of 1 mL/min using solvent A (distilled 258 
water containing 0.05% TFA) and solvent B (MeCN containing 0.05%TFA) with a linear 259 
gradient mode from 0 min to 70 min, increasing percentage of solvent B from 25% to 260 
60%. The retention times (min) of L- or D-FDLA derivatized amino acids in this HPLC 261 
condition were following; L-Arg-D-FDLA (17.23 min), L-Arg-L-FDLA (22.24 min), L-262 
Asp-L-FDLA (23.43 min), L-Tyr-D-FDLA (24.09 min), L-Ser-L-FDLA (24.16 min), L-263 
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Ser-D-FDLA (25.19min), L-Asp-D-FDLA (26.86 min), L-Glu-L-FDLA (28.12 min), L-264 
Glu-D-FDLA (30.43 min), L-Pro-L-FDLA (30.8 min), L-Ala-L-FDLA (32.69 min), L-265 
Tyr-L-FDLA (34.70 min), L-Pro-D-FDLA (35.89 min), L-Met-L-FDLA (38.53 min), L-266 
Ala-D-FDLA (39.77 min), L-allo-Ile-L-FDLA (43.43 min), L-Ile-L-FDLA (43.72 min), 267 
L-Leu-L-FDLA (44.74 min), L-Phe-L-FDLA (46.22 min), L-allo-Ile-D-FDLA (49.27 268 
min), L-Met-D-FDLA (49.33 min), L-Ile-D-FDLA (49.35 min), L-Val-D-FDLA (51.77 269 
min), L-Phe-D-FDLA (54.16 min), L-Leu-D-FDLA (59.17 min), and L-Val-L-270 
FDLA(59.67 min). 271 
Antimicrobial assays  272 
The testing microorganisms were following: E. coli, P. aeruginosa, B. subtilis, S. aureus, 273 
M. luteus, S. cerevisiae, S. pombe, A.niger, and A. oryzae. The testing microorganisms 274 
were cultivated using nutrient agar medium (peptone 5 g, beef extract 3 g, NaCl 5g, agar 275 
15 g in 1 L of distilled water, pH 7.3) for E. coli, P. aeruginosa, B. subtilis, S. aureus, M. 276 
luteus, S. cerevisiae or ISP2 agar medium (malt extract 10 g, yeast extract 4 g, glucose 4 277 
g, agar 15 g in 1 L of distilled water, pH 7.3) for S. cerevisiae, S. pombe, A.niger, A. 278 
oryzae with incubation at 30°C. The peptide was dissolved in DMSO at the concentration 279 
of 10 mg/mL.  After the testing microorganisms were inoculated on the surface of agar 280 
medium, the paper disk with 50 μg of the peptide (5 μL) or negative control (DMSO, 5 281 
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μL) was placed onto the agar plate.  After incubation for 2 days at 30 °C, the formation 282 
of inhibition zone around the well was used for evaluation of antimicrobial activity. 283 
Results and Discussion 284 
Previously, Hegemann et al. indicated the distribution of the lasso peptide biosynthetic 285 
gene cluster in proteobacteria [14, 30]. In the reports [14, 30], an interesting lasso 286 
peptide biosynthetic gene cluster was found among the genome data for Brevundimonas 287 
diminuta (Fig. 1). The biosynthetic gene cluster had a typical set of lasso peptide 288 
biosynthetic genes, including the genes breA (accession number: EGF94505.1), breB 289 
(EGF94506.1), and breC (EGF94507.1). The leader peptide sequence in the lasso 290 
peptide precursor normally has the conserved sequence -Thr-X- before the core peptide 291 
sequence, and the first amino acid of the core peptide is often Gly, Ser, or Cys in most 292 
cases. However, the core peptide sequence of brevunsin started with Asp (Fig. 1), and 293 
this was unusual for a lasso peptide core peptide. It was of great interest to clarify 294 
whether this biosynthetic gene cluster functioned to afford the expected lasso peptide 295 
brevunsin. Firstly we performed detection of lasso peptide production in extract of 296 
culture of B. diminuta by HPLC and ESI-MS, following the previous report [24]. As a 297 
result, production of the expected lasso peptide brevunsin was not observed (Data not 298 
shown). Therefore, we planned to perform heterologous production of the lasso peptide 299 
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named brevunsin (Fig. 1) using the natural lasso peptide-producing strain 300 
Sphingomonas subterrenea as a host [24]. 301 
The shuttle vector pHSG396Sp was constructed by integrating par region and repA 302 
gene (shown in red, Fig. 2), following a previous report [8]. The promoter sequence of 303 
TTGACA - 17bp - TANNNGC was reported as a high expression, efficiency promoter 304 
sequence for Sphingomonas species [18, 19]. Thus, we integrated that promoter 305 
sequence (TTGACA - 17bp - TAGAGGC) upstream of the brevunsin biosynthetic gene 306 
cluster (breA, breB, and breC, shown in green, Fig 2), constructing the expression 307 
vector pHSG396Sp-12697L (Fig. 2 and Fig. S2). The expression vector pHSG396Sp-308 
12697L was transformed into S. subterrenea using electroporation.  309 
The bacterium S. subterrenea, harboring pHSG396Sp-12697L, was cultured using 310 
modified basal medium (1 L) containing chloramphenicol. A new lasso peptide 311 
brevunsin (10.2 mg) was isolated from the extract of the culture, along with the 312 
previously reported lasso peptide subterisin [24]. As a control, S. subterrenea harboring 313 
pHSG396Sp was also cultured and tested for production of brevunsin with same 314 
condition.  As a result, S. subterrenea harboring pHSG396Sp was confirmed to 315 
produce subterisin but not brevunsin (Fig. S3). Brevunsin showed low solubility in 316 
distilled water (less than 10 µg/mL) and high solubility (more than 1 mg/mL) in DMSO 317 
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and MeOH.  To date, this yield (10.2 mg/L) is the highest yield for the heterologous 318 
production of a lasso peptide, among previous reports [10-15, 40, 41]. The molecular 319 
formula of brevunsin was confirmed to be C99H148N24O33S by accurate ESI-MS 320 
analysis, because the ion corresponding to [M+2H]2+ was observed at m/z 1117.5244 321 
(calculated m/z value: 1117.5253). The molecular formula was identical to what we 322 
expected from the precursor gene sequence (Fig. 1). To obtain the chemical structure, 323 
NMR experiments, including 1H, 13C, DEPT-135, DQF-COSY, TOCSY, NOESY, 324 
HMBC, and HSQC, were performed on brevunsin in 0.5 mL of DMSO-d6. Assignment 325 
of the constituent amino acids was accomplished using spin system identification (Table 326 
S2), although several protons and carbons could not be determined, due to the broadness 327 
of the signals in the NMR spectra. The three partial structures A-C were established 328 
mainly by the analysis of the correlations from the TOCSY and NOESY experiments 329 
(Fig. 3). To obtain further information about the amino acid sequence, MALDI-TOF 330 
MS and MS/MS analyses was performed. The product ions for brevunsin from the 331 
MALDI-TOF MS/MS analysis were suggested to correspond to the fragments of the b-332 
series (b9-b20) and y-series (y3-y5 and y9-y12), which indicated the sequence of Gly-333 
Leu-Val-Arg-Asp-Ser-Leu-Tyr-Pro-Pro-Ala-Gly at the C-terminus (Fig. 4a and Table 334 
S3). To confirm the amino acid sequence of the macrolactam ring, a cleavage reaction at 335 
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the C-terminus peptide bond of Met was performed using cyanogen bromide (CNBr) 336 
[6]. After the CNBr reaction, the cleaved brevunsin was purified by HPLC. The 337 
molecular formula of the CNBr-cleaved brevunsin was confirmed to be C98H146N24O34 338 
by accurate ESI-MS analysis, because the ion corresponding to [M+H]2+ was observed 339 
at m/z 1102.5282 (calculated m/z value: 1102.5289). In the CNBr reaction, the Met 340 
residue of a peptide is reported to be transformed to homoserinelactone (HSL). The 341 
MALDI-TOF MS/MS of the cleaved brevunsin gave the sequence of the branched 342 
peptide with two new C-terminal ends (Fig 4b and Table S4). The product ions (b’1, 343 
b’2, and b’3) indicated the sequence of Asp-Gly-HSL at one C-terminal end. In 344 
addition, the product ions (b5, b6, y12, and y13) indicated Asp-Gly-HSL connected to 345 
Glu. These data indicated that the α-amine group of the first Asp and the γ-carbonyl 346 
group of the 8th Glu formed an isopeptide bond. The planer chemical structure of 347 
brevunsin was determined as shown in Fig. 4a, in combination with the data from the 348 
NMR analysis.  349 
To determine the stereochemistries of the constituent amino acids in brevunsin, a 350 
modified Marfey’s method [7] was applied. Briefly, the hydrolysate of brevunsin was 351 
derivatized with L-FDLA, and the stereochemistry of each amino acid was determined 352 
using HPLC analysis, by comparison with standards (Fig. S21-34). As a result, all of the 353 
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constituent amino acids were determined to be in the L form. The three-dimensional 354 
solution structure of brevunsin was calculated using the software program CNS, version 355 
1.1, based on the distance and dihedral angle restraints determined from the NOE 356 
intensities (Fig. S19) and 3JHNα coupling constants (Fig 5). The macrolactam ring 357 
consisted of nine amino acids, from Asp1 to Glu9 (yellow in Fig. 5b). The amino acids 358 
Gly10, Leu11, Val12, and Arg13 formed a loop structure, and the C-terminal amino 359 
acid residues Asp14 to Gly21 passed through the macrolactam ring. The structure of 360 
brevunsin was a typical lasso structure, which indicated that the modified genes in the 361 
brevunsin biosynthetic gene cluster functioned properly to generate the “lasso” 362 
structure, even though brevunsin had an “unusual” N-terminal amino acid with Asp in 363 
the core peptide sequence. 364 
Thermostability test on brevunsin was performed following previous report [1]. If 365 
unthreading of C-terminus linear peptide part in lasso structure happens during heating, 366 
unthreaded peptide is detected normally with shorter retention time. In this experiment, 367 
possible unthreaded brevunsin was not detected after heating treatment (95 °C for 1hr at 368 
most), which indicated thermostablity of brevunsin (Fig. S20). Macrolactam ring of 369 
brevunsin comprises of nine amino acids, which is spatially larger than macrolactum 370 
ring with seven or eight amino acids. Bulky amino acid Phe at 17th position could 371 
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contribute to the thermostability by functioning like “plug” not to unthread (Fig. S19). 372 
Some lasso peptides have been reported to have antibacterial activities [35, 21, 17]. 373 
Therefore, we performed an antibacterial activity assay on brevunsin. Following a 374 
previous report [22], the paper disk diffusion method was applied with testing 375 
microorganisms (bacterial strains, including Escherichia coli, Pseudomonas 376 
aeruginosa, Bacillus subtilis, Staphylococcus aureus, and Micrococcus luteus; yeast 377 
strains, including Saccharomyces cerevisiae, Schizosaccharomyces pombe; and fungal 378 
strains, including Aspergillus niger and Aspergillus oryzae. However, brevunsin did not 379 
show any antibacterial activity at the dosage of 50 μg/disk. 380 
In this report, we established a heterologous production system using S. subterranea 381 
as a host and successfully produced a new lasso peptide, brevunsin. Many unexplored 382 
lasso peptide gene clusters in proteobacteria remain to be explored for heterologous 383 
expression [14]. To the best of our knowledge, this is the first report of the heterologous 384 
production of a lasso peptide using bacteria that belong to Sphingomonas as a host. In 385 
addition, the yield of the lasso peptide brevunsin (10.2 mg/L) was high enough to 386 
perform structure determination using NMR and a biological activity test. We believe 387 
that this heterologous production system is an efficient tool for the production of other 388 
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Figure legends 527 
 528 
Figure 1. Biosynthetic gene cluster of brevunsin 529 
Figure 2. Construction of heterologous expression vector pHSG396Sp-12697L, 530 
underlined letter indicates promoter sequence, bold letter indicates XbaI recognition site 531 
Figure 3. Key 2D NMR correlations to construct three partial structures A-C (bold line: 532 
TOCSY, double ended arrow: NOESY) 533 
Figure 4. a) MS/MS experiment on brevunsin, b) MS/MS experiment on CNBr-cleaved 534 
brevunsin 535 
Figure 5. NMR-derived structures of brevunsin: (a) superposition of the 15 lowest-536 
energy structures and (b) the lowest-energy structure of brevunsin. The isopeptide bond 537 
between Asp1 and Glu9 is shown in red. The ring-forming residues are shown in 538 
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Figure 1. Biosynthetic gene cluster of brevunsin 543 
Figure 2. Construction of heterologous expression vector pHSG396Sp-12697L, 544 
underlined letter indicates promoter sequence, bold letter indicates XbaI recognition 545 
site. 546 
Figure 3. Key 2D NMR correlations to construct three partial structures A-C 547 
Figure 4. a) MS/MS experiment on brevunsin, b) MS/MS experiment on CNBr-cleaved 548 
brevunsin 549 
Figure 5. NMR-derived structures of brevunsin: (a) superposition of the 15 lowest-550 
energy structures and (b) the lowest-energy structure of brevunsin. The isopeptide bond 551 
between Asp1 and Glu9 is shown in red. The ring-forming residues are shown in 552 
yellow, and the loop and the tail in blue.   553 
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